The clinical and biological significance of HER2 over-expression in breast ductal carcinoma in situ: a large study from a single institution.

Br J Cancer · 2019 · PMC6738110 · PMID 31065110

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

HER2 positivity alone was not predictive of recurrence as a whole or as invasive disease but showed a trend to DCIS recurrence.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.